triethylenemelamine has been researched along with Osteoporosis in 1 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| PICCINI, A | 1 |
| TARGETTI, M | 1 |
1 other study available for triethylenemelamine and Osteoporosis
| Article | Year |
|---|---|
[MALIGNANT HISTOPLASMOCYTOSIS (A STATISTICO-CLINICAL STUDY)].
Topics: Adrenal Cortex Hormones; Albuminuria; Alkaline Phosphatase; Androgens; Asthenia; Blood Protein Elect | 1963 |